Classification of Breast Cancer According to ERBB2 Immunohistochemistry Scores
JAMA Oncol
.
2023 Sep 1;9(9):1298-1299.
doi: 10.1001/jamaoncol.2023.2635.
Authors
Charles J Robbins
1
,
Aileen I Fernandez
2
,
David L Rimm
3
Affiliations
1
Yale University School of Medicine, New Haven, Connecticut.
2
Yale University, New Haven, Connecticut.
3
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.
PMID:
37498606
DOI:
10.1001/jamaoncol.2023.2635
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Breast Neoplasms* / genetics
Female
Humans
Immunohistochemistry
Receptor, ErbB-2 / genetics
Substances
Receptor, ErbB-2
ERBB2 protein, human